TaurineNCT06884566
Effect of Acute Supplementation (taurine) on Maximal Strength and Anaerobic Power
A study testing Taurine supplementation in people with Taurine, run by University of Central Lancashire Cyprus at 1 site in Cyprus.
Trial summary
This crossover-design study examines the acute effect of taurine on trained individuals aged 18-40 on strength and power outputs. Read more about this study
- Who is it for?
- Ages 18 to 40 yearsHealthy volunteers can take part
- Conditions the study is for
- Taurine
- What is being tested?
- Taurine supplementation
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 17 participants
- Where
- 1 siteCyprus
- Study dates
- 7 Jan 2025to 21 Jan 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 40 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- participants 18 - 40 years of age
- physically active or recreationally active with consistent training more than 3 times per week for at least 6 months
- non-smokers
Who cannot join
- cardiovascular, respiratory or metabolic diseases
- any musculoskeletal injury in the last six months
- taking taurine and/or creatine supplementation in the past three months
Trial locations and contacts
1 site in 1 country.
About this study
This crossover-design study examines the acute effect of taurine on trained individuals aged 18-40 on strength and power outputs.
Read the detailed description
The purpose of this study is to further investigate any potential ergogenic effects offered by taurine, under specific conditions, namely that of acute supplementation, as opposed to the chronic supplementation protocols of many popular ergogenic aids, such as creatine and beta alanine. Exercise modes investigated include maximal isometric strength, maximal instantaneous power generation, and sustained maximal anaerobic power output, investigated via grip strength, vertical jump height, and the Wingate test, respectively.
- Conditions
- Taurine
- Being tested
- Taurine supplementation, Placebo
- Keywords
- Taurine, Power, Strenght, Exercise
- Medical subject headings
- Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Taurine supplementationDietary supplement
For the intervention trials participants consumed the following in randomized order: 50mg·kg -1 of taurine diluted in 500ml of a sugar-free lemonade drink or placebo which was a sugar-free lemonade drink with nothing added, 60 minutes before the exercise protocols. Participants wore a nose plug during consumption to confirm that no taste differences were discernible between trials.
PlaceboDietary supplement
For the intervention trials participants consumed the following in randomized order: 50mg·kg -1 of taurine diluted in 500ml of a sugar-free lemonade drink or placebo which was a sugar-free lemonade drink with nothing added, 60 minutes before the exercise protocols. Participants wore a nose plug during consumption to confirm that no taste differences were discernible between trials.
| Study group | Role | What they receive |
|---|---|---|
| Taurine supplementation | Experimental | Participants consumed 50mg·kg -1 of taurine diluted in 500ml of a sugar-free lemonade drink. Receives: Dietary Supplement: Taurine supplementation |
| Placebo | Placebo comparator | Placebo was a 500ml sugar-free lemonade drink with nothing added Receives: Dietary Supplement: Placebo |
What is being measured
The primary outcome is the main question the study is designed to answer.
Maximal Isometric strength in kilograms assessed via handgrip test
Measured: Day 1
Relative Isometric strength in kilograms assessed via handgrip test
Measured: Day 1
Maximal Instantaneous power generation in W/kg assessed via vertical jump height test.
Measured: Day 1
Average Instantaneous power generation in W/kg assessed via vertical jump height test.
Measured: Day 1
Peak power in Watts assessed via the Wingate Anaerobic test
Measured: Day 1
Maximal Isometric strength in kilograms assessed via handgrip test
Measured: After 48 hours
Relative Isometric strength in kilograms assessed via handgrip test
Measured: After 48 hours
Maximal Instantaneous power generation in W/kg assessed via vertical jump height test.
Measured: After 48 hours
Average Instantaneous power generation in W/kg assessed via vertical jump height test.
Measured: After 48 hours
Peak power in Watts assessed via the Wingate Anaerobic test
Measured: After 48 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Mar 2025
- Study start7 Jan 2025
- Primary completion21 Jan 2025
- Study completion21 Jan 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for TaurineStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 17 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Central Lancashire Cyprus
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Kyriaki Antoniou, University of Central Lancashire Cyprus
- Investigators
- Efstathios Christodoulides, PhD, Principal investigator, https://www.uclancyprus.ac.cy/
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06884566
- Sponsor's protocol ID
- ΕΕΒΚ/ΕΠ/2024/76
- Status last verified
- Jan 2025
- First submitted
- 23 Jan 2025
- Last updated
- 19 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Acute Supplementation (taurine) on Maximal Strength and Anaerobic Power
- ClinicalTrials.gov ID
- NCT06884566
- Acronym / sponsor ID
- ΕΕΒΚ/ΕΠ/2024/76
- Conditions
- Taurine
- Keywords
- Taurine, Power, Strenght, Exercise
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 17 participants (actual)
- Lead sponsor
- University of Central Lancashire CyprusUniversity, hospital or other
- Study start
- 7 Jan 2025 (actual)
- Primary completion
- 21 Jan 2025 (actual)
- Study completion
- 21 Jan 2025 (actual)
- First posted
- 19 Mar 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This crossover-design study examines the acute effect of taurine on trained individuals aged 18-40 on strength and power outputs.
Detailed description
The purpose of this study is to further investigate any potential ergogenic effects offered by taurine, under specific conditions, namely that of acute supplementation, as opposed to the chronic supplementation protocols of many popular ergogenic aids, such as creatine and beta alanine. Exercise modes investigated include maximal isometric strength, maximal instantaneous power generation, and sustained maximal anaerobic power output, investigated via grip strength, vertical jump height, and the Wingate test, respectively.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Taurine supplementation | Experimental | Dietary Supplement: Taurine supplementationParticipants consumed 50mg·kg -1 of taurine diluted in 500ml of a sugar-free lemonade drink. |
| Placebo | Placebo comparator | Dietary Supplement: PlaceboPlacebo was a 500ml sugar-free lemonade drink with nothing added |
Who may qualify
- Ages
- 18 to 40 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- participants 18 - 40 years of age
- physically active or recreationally active with consistent training more than 3 times per week for at least 6 months
- non-smokers
Key exclusion criteria (3 listed)
- cardiovascular, respiratory or metabolic diseases
- any musculoskeletal injury in the last six months
- taking taurine and/or creatine supplementation in the past three months
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Taurine supplementationFor the intervention trials participants consumed the following in randomized order: 50mg·kg -1 of taurine diluted in 500ml of a sugar-free lemonade drink or placebo which was a sugar-free lemonade drink with nothing added, 60 minutes before the exercise protocols. Participants wore a nose plug during consumption to confirm that no taste differences were discernible between trials. | Dietary supplement | Taurine supplementation |
| PlaceboFor the intervention trials participants consumed the following in randomized order: 50mg·kg -1 of taurine diluted in 500ml of a sugar-free lemonade drink or placebo which was a sugar-free lemonade drink with nothing added, 60 minutes before the exercise protocols. Participants wore a nose plug during consumption to confirm that no taste differences were discernible between trials. | Dietary supplement | Placebo |
Primary outcome
Maximal Isometric strength in kilograms assessed via handgrip test
Time frame: Day 1
Relative Isometric strength in kilograms assessed via handgrip test
Time frame: Day 1
Maximal Instantaneous power generation in W/kg assessed via vertical jump height test.
Time frame: Day 1
Average Instantaneous power generation in W/kg assessed via vertical jump height test.
Time frame: Day 1
Peak power in Watts assessed via the Wingate Anaerobic test
Time frame: Day 1
Maximal Isometric strength in kilograms assessed via handgrip test
Time frame: After 48 hours
Relative Isometric strength in kilograms assessed via handgrip test
Time frame: After 48 hours
Maximal Instantaneous power generation in W/kg assessed via vertical jump height test.
Time frame: After 48 hours
Average Instantaneous power generation in W/kg assessed via vertical jump height test.
Time frame: After 48 hours
Peak power in Watts assessed via the Wingate Anaerobic test
Time frame: After 48 hours
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Mar 2025.
- Individual participant dataSharing planned: No
Related trials for Taurine
Not yet recruiting
Effects of Taurine Supplementation and Morning or Evening High-intensity Exercise on Circadian Clock Genes and Inflammatory Parameters in Adult Women With Obesity
Obesity (Disorder), Inflammation
RecruitingPhase 2
Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma
Oral Mucositis (Ulcerative) Due to Radiation, Nasopharyngeal Carcinoma (NPC)
Recruiting
Butyrate and Taurine for Chronic Postsurgical Pain in Adult Cardiac Surgical Patients
Pain, Acute, Pain, Chronic
Not yet recruitingPhase 1/2
Taurine Supplementation in Adolescents With Post-COVID Condition
Long COVID, Post COVID-19 Condition
RecruitingPhase 2
Taurine Effect on Glycemic, Lipidic and Inflammatory Profile in Individuals With Type 2 Diabetes
Diabetes Mellitus, Type 2
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Efstathios Christodoulides, PhD principal investigator
https://www.uclancyprus.ac.cy/
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Taurine supplementation in people with Taurine, run by University of Central Lancashire Cyprus at 1 site in Cyprus.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Cyprus. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Maximal Isometric strength in kilograms assessed via handgrip test (time frame: Day 1). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2025.